3/14/2014 7:06:16 AM
FDA regulators put their highest-risk label on Merit Medical's recall of kits containing 1% Lidocaine HCl injections manufactured by Hospira. FDA officials put their highest-risk Class I label on a recall of certain Merit Medical Systems (NSDQ:MMSI) procedural trays and kits over concerns about 1% Lidocaine HCl injections manufactured by Hospira (NYSE:HSP). he injections were recalled after 1 confirmed customer report of red and black particulate in the container, according to the FDA memo.
Help employers find you! Check out all the jobs and post your resume.
comments powered by